BASF to increase 1,2-PDA capacity with new China plant

By Gareth Macdonald

- Last updated on GMT

BASF to increase 1,2-PDA capacity with new China plant

Related tags Active pharmaceutical ingredients Manufacturing

BASF has announced plans for a specialty amines plant at its site on the Nanjing Chemical Industry Park in China, citing increasing demand from customers in Asia.

The plan – which is due to be operational in 2019 – will make a range of amines including 1,2-Propylenediamine (1,2-PDA), which is used as a building block in the manufacture of a wide range of active pharmaceutical ingredients (API).

Narayan Krishnamohan, senior VP of BASF’s intermediates business in Asia Pacific, said: “This investment will help us to meet the increasing Asia Pacific demand for specialty amines used as intermediates in a diverse range of industries and applications.”

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...